Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sibu is a health and wellness company that specializes in the development and commercialization of products derived from the sea buckthorn berry (Hippophae rhamnoides). The company focuses on the therapeutic benefits of Omega-7 fatty acids, which are found in high concentrations in the sea buckthorn fruit and seed oils. Sibu's product portfolio includes premium skincare, personal care items, and dietary supplements designed to support skin, hair, and nail health, as well as internal mucosal health. By utilizing a vertically integrated supply chain in the Himalayan region, the company ensures the quality and sustainability of its raw materials for both consumer and professional markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SIBU.